IR refers to the reduced ability of insulin target tissues to respond to insulin signaling, promoting compensatory hyperinsulinemia, which is closely associated with MetS and related disorders such as obesity, NAFLD, and hypertension [6]. The gene discussed is INS; the disease is obesity disorder.